Materials, Synthetic Biology, Materials Science, Consumer Products, Fundamentals.
to disrupt pharmaceuticals with biologics having grown to contribute over 32% of total industry revenues in 2018 in the US. Six of the top eight drugs by revenue in 2016 were biologics, though perhaps helped by market distortions. Fun fact: many biologics are so valuable they can be more valuable